Brandy B Ma1, Madeline C Fields2, Robert C Knowlton1, Edward F Chang3, Jerzy P Szaflarski4, Lara V Marcuse2, Vikram R Rao1. 1. Department of Neurology and Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA. 2. Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 3. Department of Neurological Surgery and Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA. 4. Department of Neurology and the UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, AB, USA.
Abstract
OBJECTIVE: Surgical resection of seizure-producing brain tissue is a gold standard treatment for drug-resistant focal epilepsy. However, several patient-specific factors can preclude resective surgery, including a spatially extensive ("regional") seizure-onset zone (SOZ). For such patients, responsive neurostimulation (RNS) represents a potential treatment, but its efficacy has not been investigated in this population. METHODS: We performed a multicenter retrospective cohort study of patients (N = 30) with drug-resistant focal epilepsy and a regional neocortical SOZ delineated by intracranial monitoring who were treated with the RNS System for at least 6 months. RNS System leads were placed at least 1-cm apart over the SOZ, and most patients were treated with a lead-to-lead stimulation pathway. Five patients underwent partial resection of the SOZ concurrent with RNS System implantation. We assessed change in seizure frequency relative to preimplant baseline and evaluated correlation between clinical outcome and stimulation parameters. RESULTS: Median follow-up duration was 21.5 months (range 6-52). Median reduction in clinical seizure frequency was 75.5% (interquartile range [IQR] 40%-93.9%). There was no significant difference in outcome between patients treated with and without concurrent partial resection. Most patients were treated with low charge densities (1-2.5 µC/cm2 ), but charge density, interlead distance, and duration of treatment were not significantly correlated with outcome. SIGNIFICANCE: RNS is a feasible and effective treatment in patients with drug-resistant regional neocortical seizures. Prospective studies in larger cohorts are necessary to determine optimal lead configuration and stimulation parameters, although our results suggest that lead-to-lead stimulation and low charge density may be effective in some patients. Wiley Periodicals, Inc.
OBJECTIVE: Surgical resection of seizure-producing brain tissue is a gold standard treatment for drug-resistant focal epilepsy. However, several patient-specific factors can preclude resective surgery, including a spatially extensive ("regional") seizure-onset zone (SOZ). For such patients, responsive neurostimulation (RNS) represents a potential treatment, but its efficacy has not been investigated in this population. METHODS: We performed a multicenter retrospective cohort study of patients (N = 30) with drug-resistant focal epilepsy and a regional neocortical SOZ delineated by intracranial monitoring who were treated with the RNS System for at least 6 months. RNS System leads were placed at least 1-cm apart over the SOZ, and most patients were treated with a lead-to-lead stimulation pathway. Five patients underwent partial resection of the SOZ concurrent with RNS System implantation. We assessed change in seizure frequency relative to preimplant baseline and evaluated correlation between clinical outcome and stimulation parameters. RESULTS: Median follow-up duration was 21.5 months (range 6-52). Median reduction in clinical seizure frequency was 75.5% (interquartile range [IQR] 40%-93.9%). There was no significant difference in outcome between patients treated with and without concurrent partial resection. Most patients were treated with low charge densities (1-2.5 µC/cm2 ), but charge density, interlead distance, and duration of treatment were not significantly correlated with outcome. SIGNIFICANCE: RNS is a feasible and effective treatment in patients with drug-resistant regional neocortical seizures. Prospective studies in larger cohorts are necessary to determine optimal lead configuration and stimulation parameters, although our results suggest that lead-to-lead stimulation and low charge density may be effective in some patients. Wiley Periodicals, Inc.
Authors: Jonathan K Kleen; Benjamin A Speidel; Maxime O Baud; Vikram R Rao; Simon G Ammanuel; Liberty S Hamilton; Edward F Chang; Robert C Knowlton Journal: Epilepsia Date: 2021-02-26 Impact factor: 5.864
Authors: Jimmy C Yang; Nitish M Harid; Fábio A Nascimento; Vasileios Kokkinos; Abigail Shaughnessy; Alice D Lam; M Brandon Westover; Thabele M Leslie-Mazwi; Leigh R Hochberg; Eric S Rosenthal; Andrew J Cole; Robert M Richardson; Sydney S Cash Journal: Ann Clin Transl Neurol Date: 2021-05-06 Impact factor: 4.511
Authors: Sharon Chiang; Ankit N Khambhati; Emily T Wang; Marina Vannucci; Edward F Chang; Vikram R Rao Journal: Brain Stimul Date: 2021-02-06 Impact factor: 8.955
Authors: Danielle S McDermott; Emily A Mirro; Kirsten Fetrow; David E Burdette; Stephanie Chen; Jennifer Hopp; Todd Masel; Emily A Johnson; Felicia M K Elefant; Scheherazade Le; Sanjay E Patra; Mesha-Gay Brown; Zulfi Haneef Journal: Epilepsia Open Date: 2021-03-13